Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remotely Observed Methadone Evaluation II
Sponsor: Sonara Health
Summary
Methadone is an effective treatment for severe opioid use disorder (OUD), but access is limited due to the requirement of daily observed dosing by most opioid treatment programs (OTPs). Sonara Health designed a HIPAA-compliant web-application called Sonara that features integrated video dosing recording, a tamper-evident seal, and an innovative measurement-based care (MBC) framework called the Opioid Craving Visual Analogue Scale (OC-VAS) to facilitate methadone take-homes while providing evidence of appropriate use and monitoring patient outcomes. Phase II of this SBIR aims to compare Sonara against usual take-homes to assess its impact on retention in care, opioid use, patient outcomes, and costs of care.
Official title: Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-12-24
Completion Date
2027-04-30
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Sonara
Sonara virtual dosing window and engagement platform
Locations (1)
FGC Wabash
Chicago, Illinois, United States